Treatment of infant hyperbilirubinemia using low dosages of...

Details Treatment of infant hyperbilirubinemia using low dosages of... Treatment of infant hyperbilirubinemia using low dosages of...

A - Human Necessities

61

K

A61K 31/409 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2664934

Methods of treating infant hyperbilirubinemia using stannsoporfin are disclosed. The methods of the invention permit treatment of various patient populations at lower doses of stannsoporfin than previously believed effective, providing advantages in therapeutic administration.

L'invention concerne des méthodes de traitement de l'hyperbilirubinémie infantile en utilisant de la stannsoporfine. Les méthodes selon l'invention permettent de traiter diverses populations de patients à des doses de stannsoporfine inférieures à celles qui étaient auparavant considérées efficaces, fournissant ainsi des avantages en termes d'administration thérapeutique.

Affiliated with

Also associated with

Rating

Treatment of infant hyperbilirubinemia using low dosages of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of infant hyperbilirubinemia using low dosages of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of infant hyperbilirubinemia using low dosages of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1970962